ArticleUrolithiasis2026
Thirty-day outcomes of Direct In-Scope Suction (DISS) in real-world practice using magneto, MOSES, and Thulium fiber laser technologies for renal and ureteral stones: an EAU endourology study.
Article in Urolithiasis, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
25 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Direct in-scope suction (DISS) ureteroscopy integrates aspiration through the ureteroscope working channel, but the interaction between suction and contemporary laser platforms is incompletely defined. We prospectively compared MOSES high-power holmium: YAG, thulium fiber laser (TFL), and Magneto holmium: YAG during DISS-assisted flexible ureteroscopy across 16 centres in 14 countries. Adults treated between May and December 2025 underwent baseline and 30-day non-contrast computed tomography (NCCT). The primary efficacy endpoint was zero-residual-fragment stone-free status (ZRF-SFS; Grade A) on 30-day NCCT; Grade B denoted a single residual fragment ≤ 2 mm. Among 502 patients, 146 received MOSES, 198 TFL, and 158 Magneto. Median operative time was 60, 44, and 40 min, and ureteroscopy time 49, 36, and 27 min, respectively (both p < 0.001). Working-channel blockage requiring flushing was most frequent with TFL (7.5%, 17.7%, and 1.3%; p < 0.001), while scope malfunction requiring change was most frequent with MOSES (7.5%, 0.5%, and 0.6%; p < 0.001). Grade A ZRF-SFS was similar (71.0%, 71.2%, and 72.2%), whereas Grade A + B stone-free status was 86.2%, 96.0%, and 98.1%. Laser platform was not independently associated with Grade A clearance; increasing stone volume was the only significant predictor of lower clearance (OR 0.63 per 1 cm³ [1000 mm³], 95% CI 0.46-0.86). Thus, complete CT-confirmed clearance was comparable across platforms, while operative and device-related differences should be interpreted as exploratory because laser allocation and perioperative practice were centre-dependent.
Indexed as
Identifiers
42870008What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.